Announcement for the Company’s full receipt of payment and the record date for cash capital increase before IPO.

1. Date of occurrence of the event:2023/09/15
2. Company name : Diamond Biofund Inc.
3. Relationship to the Company (please enter ”head office” or”subsidiaries”):Head office.
4. Reciprocal shareholding ratios : N/A
5. 5.Cause of occurrence:In accordance with Subparagraph 2, Paragraph 1, Article 9 of the ”Regulations Governing the Offering and Issuance of Securities by Securities Issuers.”
6. Countermeasures : None.
7. Any other matters that need to be specified(the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.):

(1)The Company increases capital by cash and issues 100,000 thousand common shares prior to the initial listing. The minimum underwriting price of the competitive auction is NT$37.74 per share. Securities shall be awarded on the basis of bid price in descending order, and each successful bidder shall subscribe the securities at the bidder’s own bid price. The weighted average of the bid price of all successful bids is NT$47.18. The underwriting price of public subscription is NT$40 per share. The total amount of payment forsubscription is NT$4,488,111,630, which has been fully received.

(2)The record date of cash capital increase: 2023/09/15